StereotaxisSTXS -1.23%66 PB Ratio is 10.95 as of Jun. 25, 2026, which is 16% below its 10-year median of 13.07. GuruFocus rates STXS with a GF Score™ of 66/100 and a GF Value™ of $2.31 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Stereotaxis ranks worse than 92.64% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Stereotaxis's share price is $1.61. Stereotaxis's Book Value per Share for the quarter that ended in Mar. 2026 was $0.15. Hence, Stereotaxis's PB Ratio of today is 10.95.
Good Sign:
Stereotaxis Inc stock PB Ratio (=11.09) is close to 2-year low of 10.28.
The historical rank and industry rank for Stereotaxis's PB Ratio or its related term are showing as below:
STXS'
s PB Ratio Range Over the Past 10 Years
Min: 4.13 Med: 13.07 Max: 172.94
Current: 10.73
During the past 13 years, Stereotaxis's highest PB Ratio was 172.94. The lowest was 4.13. And the median was 13.07.
STXS's PB Ratio is ranked worse than 92.64% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs STXS: 10.73
During the past 12 months, Stereotaxis's average Book Value Per Share Growth Rate was 345.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -26.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -29.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Stereotaxis was 174.10% per year. The lowest was -50.90% per year. And the median was -20.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Stereotaxis PB Ratio Related Terms
Stereotaxis PB Ratio Historical Data
* Premium members only.
The historical data trend for Stereotaxis's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Stereotaxis's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stereotaxis PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's PB Ratio distribution charts can be found below:
* The bar in red indicates where Stereotaxis's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Stereotaxis's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Stereotaxis (STXS) has a PB Ratio of 10.95 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Stereotaxis and its competitors. This is 16% below median its historical median of 13.07. Over the past decade, Stereotaxis' PB Ratio has ranged from 4.13 to 172.94. According to the industry distribution chart, Stereotaxis ranks #730 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 92.6%.
Is Stereotaxis' PB Ratio too high?
Stereotaxis' current PB Ratio of 10.95 is 16% below median its 10-year median of 13.07. Over the past 10 years, this metric has ranged from a low of 4.13 to a high of 172.94. The Medical Devices & Instruments industry median PB Ratio is 2.05. Stereotaxis' value of 10.95 is 435.5% above this industry median. Based on the distribution chart, Stereotaxis ranks #730 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stereotaxis has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' PB Ratio compare to EMBC and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Stereotaxis ranks #730 out of 788 companies for PB Ratio. This places Stereotaxis in the lower half of its industry. The industry median PB Ratio is 2.05. Stereotaxis' value of 10.95 is 435.5% above this benchmark. Historically, Stereotaxis' own PB Ratio has ranged from 4.13 to 172.94 over the past decade. While the company's 10-year median is 13.07 vs. the industry median of 2.05, Stereotaxis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stereotaxis's current PB Ratio of 10.95 is 435.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Stereotaxis and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stereotaxis's current PB Ratio is 10.95, which is 16% below median its own 10-year median of 13.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.31, compared to a current price of $1.61 — trading 30.3% below its estimated fair value. The current PB Ratio is 10.95, which is 16% below median its 10-year median of 13.07 and 435.5% above the Medical Devices & Instruments industry median of 2.05. Stereotaxis' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Stereotaxis (STXS), the current PB Ratio is 10.95 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stereotaxis (STXS) Overvalued in 2026?
Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued.
The current stock price of $1.61 is trading 30.3% below its estimated GF Value™ of $2.31.
GuruFocus considers Stereotaxis to be Possible Value Trap.
Key valuation signals for STXS:
PB Ratio: 10.95 (16% below median its 10-year median of 13.07)
GF Value™: $2.31 vs. price of $1.61 (30.3% below fair value)
Industry Position: 435.5% above the Medical Devices & Instruments median (#730 of 788)
No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
66GF Score
Get the complete analysis for STXS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STXS has been successfully added to your 
